Search / Trial NCT00000414

Patient Education in Rheumatoid Arthritis and Osteoarthritis

Launched by STANFORD UNIVERSITY · Nov 3, 1999

Trial Information

Current as of December 27, 2024

Completed

Keywords

Rheumatoid Arthritis (Ra) Osteoarthritis (Oa) Arthritis Education Health Care Service Evaluation Outcomes Research Arthritis Self Management Program (Asmp) Self Managed Arthritis Relief Therapy (Smart) Program

ClinConnect Summary

In a changing health care environment, the role of patients in managing their arthritis is increasingly important. Patient education is the primary means for teaching patients how to fulfill this role successfully. The goal of self-management health education is not merely to provide information but also to change patient attitudes and behavior so that patient outcomes are improved. These programs represent a new treatment for arthritis.

This project will evaluate the relative effect on health status and cost-effectiveness of two arthritis patient education programs that use different deli...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Physician diagnosis of OA or RA
  • Participation in the ARAMIS longitudinal study
  • Exclusion Criteria:
  • Age under 18

Trial Officials

Kate R. Lorig, DrPH

Principal Investigator

Stanford University

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Pittsburgh, Pennsylvania, United States

Palo Alto, California, United States

Wichita, Kansas, United States

Nashville, Tennessee, United States

Edmonton, Alberta, Canada

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials